Early and appropriate empiric antibiotic treatment of patients suspected of having sepsis is associated with reduced mortality. The increasing prevalence of antimicrobial resistance risks eroding the benefits of such empiric therapy. This problem is particularly severe for children in developing country settings. We hypothesized that by applying machine learning approaches to readily collected patient data, it would be possible to obtain actionable and patient-specific predictions for antibiotic-susceptibility. If sufficient discriminatory power can be achieved, such predictions could lead to substantial improvements in the chances of choosing an appropriate antibiotic for empiric therapy, while minimizing the risk of increased selection for resistance due to use of antibiotics usually held in reserve.
susceptibility to neither, and 0.69 (0.53-0.85) for Gram stain result. The most important variables for predicting susceptibility were time from admission to blood culture, patient age, hospital versus community-acquired infection, and age-adjusted weight score.
Conclusions Applying machine learning algorithms to patient data that are readily available even in resource-limited hospital settings can provide highly informative predictions on susceptibilities of pathogens to guide appropriate empiric antibiotic therapy. Used as a decision support tool, such approaches have the potential to lead to better targeting of empiric therapy, improve patient outcomes and reduce the burden of antimicrobial resistance.
Author summary
Why was this study done?
• Early and appropriate antibiotic treatment of patients with life-threatening bacterial infections is thought to reduce the risk of mortality.
• In hospitals that have a microbiology laboratory, it takes 3-4 days to get results which indicate which antibiotics are likely to be effective; before this information is available antibiotics have to be prescribed empirically i.e. without knowledge of the causative organism.
• Increasing resistance to antibiotics amongst bacteria makes finding an appropriate antibiotic to use empirically difficult; this problem is particularly severe for children in developing country settings.
• If we could predict which antibiotics were likely to be effective at the time of starting antibiotic therapy, we might be able to improve patient outcomes and reduce resistance.
What Did the Researchers Do and Find?
• We evaluated the ability of a number of different algorithms (i.e. sets of step-by-step instructions) to predict susceptibility to commonly-used antibiotics using routinely available patient data from a children's hospital in Cambodia.
• We found that an algorithm called random forests enabled surprisingly accurate predictions, particularly for predicting whether the infection was likely to be treatable with ceftriaxone, the most commonly used empiric antibiotic at the study hospital.
• Using this approach it would be possible to correctly predict when a different antibiotic would be needed for empiric treatment over 80% of the time, while recommending a different antibiotic when ceftriaxone would suffice less than 20% of the time.
What Do These Findings Mean?
• Using readily available patient information, sophisticated algorithms can enable good predictions of whether antibiotics are likely to be effective several days before laboratory tests are available.
Introduction 1
There is consistent evidence that early and appropriate treatment of sepsis can reduce 2 mortality [1] . Since definitive identification of a bacterial pathogen and its antibiotic 3 susceptibility typically takes three to four days using conventional culture methods, 4 empiric antibiotic therapy (i.e. therapy that starts before the causative organism and its 5 antibiotic susceptibility is known) is recommended. Choice of empirical antibiotic aims 6 to balance two objectives: first, to cast a wide spectrum of coverage effective against the 7 most likely causative organisms; second, to minimize the selection of resistance to 8 reserve antibiotics in the wider population [2] . Balancing the consequences associated 9 with these two concerns -immediate patient outcomes and long-term resistance patterns 10 impacting on future patients -represents a major challenge.
11
Empiric antibiotic choice for invasive bacterial infections in hospitalized children in 12 low-to-middle income countries (LMICs) constitutes a particularly stark example of this 13 problem owing to the high attributable mortality [3], and the high prevalence of 14 antimicrobial resistance, particularly in neonates [4] .
15
Current World Health Organization (WHO) guidelines for suspected sepsis or serious 16 bacterial infection in newborns recommend empirical usage of gentamicin and ampicillin 17 as the first line therapy, and change to third-generation cephalosporins if there is lack of 18 improvement in 24-72 hours. [5, 6] However, a systematic review of community-acquired 19 neonatal sepsis in developing countries in 2012 found that of the causative pathogens in 20 older infants (1-12 months), only 63% and 64% showed in vitro susceptibility to 21 ampicillin and gentamicin, and third-generation cephalosporins, respectively. [6] For 22 neonates, susceptibilities were even lower, with only 57% and 56% of pathogens 23 susceptible to ampicillin and gentamicin and third-generation cephalosporins, 24 respectively.
25
The potential harms of widespread antimicrobial resistance in children were 26 illustrated in a recent study performed between 2007 and 2016 in a Cambodian 27 children's hospital, which found those infected with third-generation 28 cephalosporin-resistant bacteria were less likely than others to receive appropriate 29 antimicrobial therapy (57% vs. 94%), and when appropriate therapy was administered, 30 it was initiated later (2 days vs. 0 days after admission for those who survived; 0.5 days 31 vs. 0 days for those who died) [7] . In multivariable logistic regression, third-generation 32 cephalosporin resistance was independently associated with death (aOR 2.65, 95% CI have been developed to help identify patients at high risk of being infected with 48 multidrug-resistant pathogens. These approaches have primarily been developed in high-49 and upper middle-income countries [13] [14] [15] [16] [17] [18] . The use of predictive modeling as part of 50 clinical decision support systems for antimicrobial management remains rudimentary, 51 with only one example identified in a recent systematic review [19] . It has, however, 52 been demonstrated in a randomized trial (in Israel, Germany and Italy) that a 53 computerized decision support systems making use of an underlying causal probabilistic 54 network model can lead to more appropriate empiric antibiotic prescribing [20] . 55 We hypothesized that applying modern machine learning approaches to readily 56 collected patient data can surpass the performance of those based on logistic regression 57 or simple decision trees, and derive patient-specific predictions for antibiotic 58 susceptibility. Improved predictions directing empirical antibiotic therapy may 59 contribute to better patient outcomes while avoiding the overuse of inappropriate 60 antibiotics that select for resistance.
61
In this study, we propose a locally adapted decision support system for a Cambodian 62 children's hospital by applying an array of machine learning algorithms to patient-level 63 data. We evaluated the ability of the algorithms to predict whether the causative 64 organisms were susceptible to (i.e. treatable with): i) ampicillin and gentamicin; ii) 65 ceftriaxone ; iii) neither i) nor ii). We specifically focus on the value of using the 66 predictive models to identify patients at high risk of being infected with organisms 67 resistant to ceftriaxone, a third-generation cephalosporin and the most commonly 68 prescribed empirical antibiotic in practice at our study site. Blood cultures are routinely taken from febrile inpatients (axillary temperature 81 > 37.5 • C) in accordance with clinical algorithms. Processing of these cultures including 82 in vitro antibiotic susceptibility testing has been described elsewhere [21] . Children with 83 at least one positive blood culture for a bacterial pathogen (other than coagulase 84 negative Staphylococci and other likely skin contaminants) isolated between February 85 2013 and January 2016 were included in this study. We considered routine clinical data 86 collected by the hospital and data on living conditions including household size, presence 87 of domestic animals, and factors relating to water and sanitation. The study was
Data Analysis

91
We evaluated a suite of machine learning algorithms based on their ability to predict the 92 invasive pathogens' Gram stain and in vitro susceptibility to antibiotics using available 93 information prior to receiving culture results. Specifically, the antibiotics considered 94 were: i) ampicillin and gentamicin; ii) ceftriaxone; iii) either i) or ii). In the event that 95 more than one organism was grown from the same blood culture, they were categorized 96 as susceptible to the specified antibiotics only if all organisms were susceptible to at 97 least one.
98
To predict the above four dependent variables we selected 35 independent variables 99 (predictors) from patient records by coding quality and relevance. Dichotomous 100 predictors where all but 10 or fewer patients had the same value were excluded. Missing 101 data for binary predictors were treated as negative (e.g. NA for domestic animal was 102 considered no domestic animal).
103
Weight for age standard deviations (z-score), a measure of malnutrition, was An 80/20 split for training and testing data set was adopted. For categorical 120 variables we ensured that each category was represented by at least one record in the 121 training set. To assess algorithm performance over different training sets, each model 122 was refitted to 100 random selections of training and testing data sets. Performance was 123 ranked based on area under the receiver operating characteristic curve (AUC) from the 124 test set.
125
For each method we report both the performance ranking for different outcomes, 126 and then consider each method's individual performance. We select the best method 127 overall, then consider its probability calibration and the most important predictors.
128
Variable importance in random forests was calculated using the method described in However, they do not tell us what optimal cut-off for specificity we should use in 135 practice. One possible approach would be to choose this cut-off to maximize the overall 136 test accuracy (i.e. the chance the test gives a true positive or true negative result). cut-off will be a value of the specificity that minimizes this net monetary loss. We 156 provide illustrative examples of these calculations (see S1 Appendix for further details) 157 and provide a user-friendly web application to enable optimal cut-offs to be determined 158 under different assumptions, available at https://mathu.shinyapps.io/rf-ceft-cost/. Comparing relative performance of the approaches based on the AUC, the random 164 forest method was most frequently ranked first, and was consistently ranked higher than 165 decision trees, boosted decision trees, k-nearest neighbors, and the widely-used stepwise 166 logistic regression. Of the four dependent variables, lack of susceptibility to ampicillin 167 and gentamicin (Fig 2A) , and to ampicillin, gentamicin and ceftriaxone ( Fig 2C) were 168 best predicted by the random forest approach. 169 Overall, the SVM approaches performed well, but with some variation depending on 170 July 11, 2018 6/19 which kernel the models were based on and which outcomes were being considered. For 171 example, an SVM with radial kernel outperformed the random forest approach by a 172 small margin in predicting lack of ceftriaxone susceptibility ( Fig 2B) , but performed 173 quite poorly for predicting lack of susceptibility to ampicillin and gentamicin (Fig 2A) . 174 None of the three SVM variants performed well for all four of the outcomes. Even the 175 algorithms that performed worst overall performed best for some of the 176 randomly-selected training/test data splits. Thus, while the k-nearest neighbors method 177 was most frequently ranked the lowest out of all the methods, for a small number of 178 random selections of training data this algorithm was the best for predicting Gram stain 179 and lack of susceptibility to all three antibiotics.
180
Ranking, although a good indicator of relative performance, does not necessarily 181 indicate prediction ability itself. Fig 3 shows Receiver Operating Characteristic (ROC) 182 curves for predicting lack of susceptibility to ceftriaxone for all methods. This figure   183 highlights the disconnect between predictive performance on the training data set (blue 184 dotted line) and that on the test set (black dashed lines), highlighting the importance of 185 separating the training and testing data. It is possible for ROC curves for different 186 methods to cross, indicating that optimal methods may vary depending on the cut-off 187 used, and that the methods with the highest AUC may not always be the best for a 188 given application. Importantly, the random forest test set ROC curve did not cross with 189 other test set ROC curves.
190
To be effective in supporting decisions, it is useful to not only rank well (predict 191 correctly), but also to be well-calibrated (i.e. the estimated probabilities that pathogens 192 lack susceptibility to an antibiotic should be similar to observed frequencies). A The most important predictors in the random forest model for the other three 210 outcomes were broadly similar. Interestingly, the classification of infection as hospital-211 or community-acquired had less importance for predicting lack of susceptibility to 212 ampicillin and gentamicin compared to ceftriaxone, but household size was found to 213 much more important.
214
For comparison, in the widely-used stepwise-selected logistic regression model, 215 important predictors in multivariable models for treatability by ceftriaxone were age, 216 household size, meningitis, and hospital-versus community-acquired infection ( Table 1) . 217 With the exception of meningitis, all these predictors ranked high in coverage (top 218 five) on importance in the random forests model. Calibration for random forest predicting lack of susceptibility to ceftriaxone. This compares predicted probabilities (grouped into 10 equally-sized bins) to observed event frequencies in real data using the entire data set. Points close to the gray diagonal line indicate that the predicted probability is close to the observed frequency. Numbers above points indicate the number of records contributing to each point. for the predicted probability that ceftriaxone would not be an effective treatment (so due to infection ( Fig 6D) . A rational approach would be to choose the threshold to antibiotics are likely to be effective. We found that the random forest approach 245 performed particularly well, especially for predicting whether pathogens were likely to 246 lack susceptibility to ceftriaxone, the most widely used empiric antibiotic for our study 247 patients. To our knowledge this is the first time such machine learning algorithms have 248 been applied to this problem.
249
The most important variables for predicting antibiotic susceptibility were found to 250 be time from admission to blood culture, patient age, age-adjusted weight score, and Used as part of a decision support system, the best machine learning approaches should, 260 in theory, make it possible to substantially increase the proportion of patients who 261 receive effective empiric antibiotics, while minimizing the risks of increased resistance 262 selection that would be associated with a blanket change in the default choice of empiric 263 antibiotics for all patients. Clearly, further work is needed to evaluate such deployment 264 in practice.
265
Rapid microbiological diagnostic tests offer an alternative pathway for improving the 266 precision of early antibiotic prescribing. Affordable and accurate tests are not currently 267 available, but this situation may change in the coming years. While machine learning 268 approaches as proposed here could be considered a stopgap, we think it is more likely 269 that the two approaches will be complementary. Results from future rapid diagnostic 270 lowering the horizontal red line in Fig 6) will capture more true cases of antimicrobial 278 resistance where a reserve antibiotic (e.g. carbapenem) is appropriate and potentially 279 improve patient outcomes (i.e. there will be more true positives). However, this will 280 inadvertently lead to more prescriptions of reserve antibiotics when they are not needed 281 (false positives), creating increased selection for resistance to what may be an antibiotic 282 of last resort. Conversely, setting the threshold at higher specificity (raising the red line 283 in Fig 6) has the benefit of reducing false positives, but the model will miss more 284 patients with resistant bacterial infections (i.e. false negatives will increase), leading to 285 delayed prescription of appropriate antibiotics. A natural approach would be to choose 286 the cut-off to maximise utility (which includes health outcomes and opportunity costs 287 associated with economic costs 
303
A second important strength of our work is that algorithm training and evaluation 304 were performed on different data sets. As is clear from Fig 3, if this is not done inflated 305 performance estimates are likely. Though there are some notable exceptions [13, 15, 18] , 306 this separation has not always been performed in the previous literature, and this would 307 be expected to lead to predictive power that is substantially lower than reported.
308
Thirdly, our analysis maximizes accuracy towards local usage. If we had used a large 309 dataset aggregated from multiple settings in the hope of increasing generalisability, 310 algorithm performance for all of the contributing centres would have been likely to 311 suffer. Generally, scoring systems developed in one setting have been found to have 312 substantially worse performance in different settings [14, 46] . Our approach focuses on 313 generalizing towards new samples obtained within the same setting with a 314 moderately-sized dataset by comparing a large number of models [47] . Importantly, this 315 suggests that the potential benefits of machine learning, which are often assumed to 316 depend on large high-quality data-sets more commonly available in high-income 317 settings [48], may be considerable even in resource-and relatively data-poor settings.
318
There are several limitations to our study. As with most clinical predictive systems, 319 generalizability is a concern. A model developed using data from one hospital, may have 320 poor predictive value when applied in another setting [14, 46] . We anticipate that wider 321 July 11, 2018 14/19 deployment of such approaches would require models to be tailored to local data. The 322 model may also become less relevant as time passes. Identifying the most appropriate 323 temporal and spatial selection windows for training data is an important area for future 324 research.
325
Understanding the algorithms 326 One potential obstacle to the wider adoption of machine learning algorithms is that, to 327 many, they are a black box. An intuitive way to understand them is to consider a 328 geometric interpretation, visualizing a smaller problem first. Suppose we have a dataset 329 with two predictors, height and weight. We can imagine each data point inhabiting a 330 point in a 2-dimensional plane, feature space (i.e. a graph with weight on the x-axis and 331 height on the y-axis). Each point would have a label of the class we are trying to 332 predict (i.e. diseased/healthy). A classification problem can be superficially phrased as 333 a search to find a line (or lines) which best separates the points with different labels on 334 its feature space. For example, a line which splits between disease and healthy people 335 on the height-weight plane. These lines do not necessarily need to be straight. For two 336 independent variables this can be visualized as a graph. For n predictors this would 337 require n-dimensions. For n > 3 this is harder to visualize, but the geometric 338 interpretation still holds.
339
A geometric visualization allows us to appreciate the varying performances of each 340 method by considering how each method arrives at the conclusion as to which line (or 341 combination of lines) is best. A decision tree can be considered a combination of 342 decisions, each represented by a line in our feature plane (i.e. is weight > 50 kg? can be 343 considered a line at 50 on the weight axis). A combination of simple lines allows for 344 more complex decision boundaries. But because of their ability to create complex 345 boundaries, they tend to overfit. Random forests are designed to correct for the habit of 346 decision trees to overfit by building a consensus of a multitude of decision trees, and 347 averaging these trees by giving the majority vote after polling all component decision 348 trees based on classification. In contrast, k-nearest neighbor, our least effective model, 349 simply considers classification based solely on the assumption that points closer in 350 feature space should be given the same classification. SVM with a radial kernel, in 351 contrast, looks for the circle that best separates points with different outcome labels.
352
Our results (Fig 2) clearly show that chance plays an important role in determining 353 which lines best separate the points (and therefore which algorithm wins), but some 354 algorithms (random forests and SVM) tend to have a much better chance of doing well. 355
Conclusion 356
Decision support systems, informed by analysis of readily available data, when 357 calibrated to local data, have the potential to lead to evidence-based hospital antibiotic 358 policies which could improve the chances patients receive the most appropriate empiric 359 antibiotics. This would be expected to lead to better patient outcomes and could help 360 minimize the risk of increasing antibiotic resistance. While guidelines for developing a 361 hospital antibiotic policy advocate conducting literature reviews and basing 362 recommendations on local cumulative surveillance antibiograms [12], we have shown 363 that machine learning algorithms informed by relatively small amounts of patient-level 364 data can be used for deriving targeted and well-calibrated patient specific predictions 365 for what empirical antibiotic therapy is likely to be appropropriate. Such a prediction 366 system can be developed cheaply, using easily-collected data, and is well-suited to LMIC 367 settings.
